Improving Lives by Creating the World’s Most Trusted Cannabis Products

Atlas Global Brands is a company that manufactures and distributes cannabis products to both the medical and recreational markets. We offer a wide range of products that are backed by high quality, medical specifications and brand-centric positioning to meet demand from secular growth sweet spots in the wider cannabis market.
 
Our pharmaceutically-viable cannabis flower and cannabis products are proudly Canadian, cultivated in Alberta and Ontario, then hand-trimmed, hand-dried, and properly curated in our state-of-the-art facilities.

THE ATLAS MISSION

Change perceptions with innovative
health and wellness alternatives
Pioneer the formulation of exclusive genetics in our
state-of-the-art agricultural facility
Attain global recognition as the premier producer of
pharmaceutically viable controlled-environment cannabis
Prove our contributions have the focus and consistency
required to set new standards of excellence in the industry
To be sought after for breakthrough product development
and genetic breeding selections that yield highly refined,
in-demand products
Amend perspectives surrounding medicinal cannabis by
providing the most comprehensive educational resources
Build upon personalized patient experiences to
consistently deliver on specific wellness needs

Why Choose Atlas Global Brands?

Consistency

Atlas Global Brands competitive advantage is its controlled-environment agricultural facility, where our industry professionals can replicate growing conditions on a consistent basis.

Capability

Our cutting-edge controlled-environment agricultural facility and integrated genetic breeding laboratory are capable of producing the highest-grade cannabis in the world. The Atlas Global Brands facility produces over 30 unique strains of cannabis, as well as a range of premium cannabis-derived products.

Competency

Our team includes PhD researchers and agricultural experts that cultivate our cannabis products. Our specialists have decades of experience in biotechnology, plant and soil chemistry, plant pathology, and cannabis cultivation. Most importantly, we have a distinctly forward-thinking and innovative attitude when it comes to cannabis cultivation and research.

Management

Bernard Yeung, MBA

Chief Executive Officer
Bernie is an accomplished sales and market executive, with almost 20 years of experience in cannabis, alcohol and consumer packaged goods industries. Bernie has held senior executive roles in cannabis, including leadership positions with multiple publicly traded licensed producers. Bernie is the former Senior Vice President, Sales & Marketing for Aphria and the newly merged Tilray. Previously, Bernie was the head of marketing for Brown Forman (parent company of Jack Daniel’s). Bernie has international experience with Dr Pepper Snapple Group and has experience navigating regulated industries with controlled products. Bernie has an MBA from Laurier University and an Honours Bachelor of Commerce degree from York University.

Jason Cervi, CPA

Chief Financial Officer
Jason has over 20 years of experience working in large global publicly traded organizations with market capitalizations in excess of US$10 billion, across several highly regulated industries including health care, medical devices, aerospace and defense, with extensive background in building and leading high performing teams. Jason has deep technical and operational knowledge and expertise in M&A and business integrations. Jason is a Chartered Professional Account and holds a Bachelor of Commerce degree with a minor in Economics from DeGroote school of business at McMaster University.

Natalie Douglas

Corporate Secretary
Natalie is a corporate paralegal whose primary focus has been supporting publicly traded companies that operate in regulated industries. She was appointed by the Board to oversee corporate governance initiatives, including the management of board meetings and ensuring relevancy and compliance of policies and procedures. With an understanding of both the legal and business aspects of the industry, she collaborates closely with the executive team to develop and implement strategic initiatives while providing valuable legal support in business transactions and corporate maintenance. Currently pursuing an undergraduate Bachelor of Business Administration degree with a major in finance, Natalie is on the path to attend law school at the University of Alberta.

Directors

Cale Alacer, P.Eng., PMP

Founding Director
Responsible for a portfolio of projects and services to help modernize the services, technologies and operations of one the Canadian federal government's largest departments. Founder and long-standing member of Atlas Growers’ Board of Directors, where he served as the chair of the Audit Committee and the Strategic Planning Committee. Holds a Professional Engineering designation and was previously certified as a Professional Cloud Architect and is Lean Six Sigma and PMP certified.

Dr. Trevor Henry, DVM

Director
CEO of AgMedica (prior to the merger of Atlas). Over 25 years of entrepreneurial and veterinary experience being the Founding Partner and President of a multi practice Veterinary Corporation in Ontario.

Elan MacDonald, ICD.D

Director
Founder and CEO of IMPACT Consulting, a leading government relations firm, which was acquired by Global Public Affairs. Currently Vice President, External Relations at the University of Alberta, Elan is also Vice Chair of Covenant Health, Chair of the Real Estate Council of Alberta (Regulator), Director of Alberta Machine Intelligence Institute (AMII), Past Chair of the Edmonton Chamber of Commerce and former Director of Edmonton Global.

Peter Van Mol, CPA, CA

Director
Co-Founder and Chief Financial Officer of AgMedica (prior to the merger of Atlas). Has held senior executive roles in cannabis since before recreational legalization. Over 30+ years of corporate finance experience supporting 10-fold revenue growth for large diversified agricultural companies with operations across Canada.

Advisors

Jonathan Ben-Cnaan

Vice Chairman of the Advisory Board
Experienced CFO in rapid growth companies, in international mergers and acquisitions, and in capital markets. Previously, as Chief Financial Officer of Bateman Engineering NV, Mr. Ben-Cnaan played a key role in its development from US$120 million to US$650 million in revenue, with a substantial part of the growth coming from acquisitions he carried out in Australia, India, South Africa and Canada.

Dr. Tamir Gedo, PhD

Executive Chairman of the Advisory Board
Founder and former CEO of BOL Pharma, the leading Israeli cannabis company, integrated through the value chain. Former Chairman, cannabis section at the Industrial Association of Israel. CEO of Beyond Oil, a CSE-listed food technology company.

David Pappo

Advisor
Chairman of the Israeli Association of Pharmacists; Head Pharmacist, Tlalim Pharmacy.

Careers

If you’re a progressive thinker with a positive attitude we would like to hear from you. Apply here via our online career site.

Scroll to Top